BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 28079894)

  • 21. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1.
    Lv P; Luo YF; Zhou WY; Liu B; Zhou Z; Shi YZ; Huang R; Peng C; He ZL; Wang J; Zhang HH; Nie SD
    Kaohsiung J Med Sci; 2020 Jun; 36(6):429-440. PubMed ID: 32125086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
    Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
    Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
    Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
    Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Genet Test Mol Biomarkers; 2015 Jan; 19(1):30-6. PubMed ID: 25494962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis.
    Fornari F; Pollutri D; Patrizi C; La Bella T; Marinelli S; Casadei Gardini A; Marisi G; Baron Toaldo M; Baglioni M; Salvatore V; Callegari E; Baldassarre M; Galassi M; Giovannini C; Cescon M; Ravaioli M; Negrini M; Bolondi L; Gramantieri L
    Clin Cancer Res; 2017 Jul; 23(14):3953-3965. PubMed ID: 28096271
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
    Li X; He J; Ren X; Zhao H; Zhao H
    Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiR-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma.
    Shan Y; Li P
    Yonsei Med J; 2019 Sep; 60(9):842-853. PubMed ID: 31433582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
    Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ
    J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
    Xu Y; An Y; Wang Y; Zhang C; Zhang H; Huang C; Jiang H; Wang X; Li X
    Oncol Rep; 2013 May; 29(5):2019-24. PubMed ID: 23483142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
    Jiang C; Long J; Liu B; Xie X; Kuang M
    Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
    Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.
    Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
    Zhang X; Cheng SL; Bian K; Wang L; Zhang X; Yan B; Jia LT; Zhao J; Gammoh N; Yang AG; Zhang R
    Oncotarget; 2015 Feb; 6(4):2277-89. PubMed ID: 25537511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.